UnitedHealth Group Incorporated (UNH)
NYSE: UNH · IEX Real-Time Price · USD
493.10
+0.79 (0.16%)
At close: Mar 27, 2024, 4:00 PM
495.63
+2.53 (0.51%)
Pre-market: Mar 28, 2024, 8:00 AM EDT
UnitedHealth Group Stock Forecast
Stock Price Forecast
The 24 analysts with 12-month price forecasts for UnitedHealth Group stock have an average target of 577.5, with a low estimate of 480 and a high estimate of 675. The average target predicts an increase of 17.12% from the current stock price of 493.10.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for UNH stock from 25 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
Buy | 14 | 14 | 13 | 13 | 13 | 14 |
Hold | 2 | 2 | 2 | 2 | 2 | 3 |
Sell | 0 | 0 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 23 | 23 | 23 | 23 | 23 | 25 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Erste Group | Erste Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 13, 2024 |
B of A Securities | B of A Securities | Strong Buy Maintains $675 | Strong Buy | Maintains | $675 | +36.89% | Mar 7, 2024 |
Barclays | Barclays | Buy Initiates $551 | Buy | Initiates | $551 | +11.74% | Mar 6, 2024 |
RBC Capital | RBC Capital | Buy Reiterates $596 | Buy | Reiterates | $596 | +20.87% | Feb 29, 2024 |
Stephens & Co. | Stephens & Co. | Buy Reiterates $605 | Buy | Reiterates | $605 | +22.69% | Feb 8, 2024 |
Financial Forecast
Revenue This Year
405.16B
from 371.62B
Increased by 9.02%
Revenue Next Year
436.26B
from 405.16B
Increased by 7.68%
EPS This Year
28.09
from 23.86
Increased by 17.75%
EPS Next Year
31.69
from 28.09
Increased by 12.78%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 424.4B | 460.5B | 506.9B | 547.0B | 550.3B |
Avg | 405.2B | 436.3B | 472.7B | 512.4B | 529.4B |
Low | 387.5B | 405.8B | 448.3B | 483.9B | 513.6B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 14.2% | 13.6% | 16.2% | 15.7% | 7.4% |
Avg | 9.0% | 7.7% | 8.3% | 8.4% | 3.3% |
Low | 4.3% | 0.2% | 2.8% | 2.4% | 0.2% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 29.59 | 33.44 | 38.15 | 43.52 | 47.20 |
Avg | 28.09 | 31.69 | 35.78 | 41.51 | 45.40 |
Low | 26.49 | 29.78 | 32.33 | 39.93 | 44.05 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 24.0% | 19.0% | 20.4% | 21.6% | 13.7% |
Avg | 17.7% | 12.8% | 12.9% | 16.0% | 9.4% |
Low | 11.0% | 6.0% | 2.0% | 11.6% | 6.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.